Scottish HPV Reference Laboratory, Royal Infirmary of Edinburgh, Edinburgh, UK.
Argentinian HPV Reference Laboratory, National Institute of Infectious Diseases-ANLIS "Dr Malbran", Buenos Aires, Argentina.
Int J Gynecol Cancer. 2023 May 1;33(5):802-811. doi: 10.1136/ijgc-2022-004197.
The recommendation for cervical screening is that it should be based on human papillomavirus (HPV) molecular testing. For all screening programs, attention to quality assurance is required to fully realize the benefits. Internationally recognized quality assurance recommendations for HPV-based screening are needed that are ideally applicable for a variety of settings, including in low- and middle-income countries. We summarize the main points of quality assurance for HPV screening, with a focus on the selection, implementation, and use of an HPV screening test, quality assurance systems (including internal quality control and external quality assessment), and staff competence. While we recognize that it might not be possible to fulfill all points in all settings, an awareness of the issues is essential.
宫颈癌筛查的建议基于人乳头瘤病毒（HPV）分子检测。所有的筛查项目都需要注重质量保证，以充分实现其效益。需要制定国际认可的 HPV 筛查质量保证建议，这些建议理想情况下适用于各种环境，包括低收入和中等收入国家。我们总结了 HPV 筛查质量保证的要点，重点是 HPV 筛查试验的选择、实施和使用、质量保证体系（包括内部质量控制和外部质量评估）以及人员能力。虽然我们认识到在所有环境中可能无法满足所有要点，但了解这些问题是至关重要的。
